Tracking a new Drug's Real-Life impact on rare tumor patients
NCT ID NCT07075471
Summary
This study aims to learn how patients with a rare, non-cancerous joint tumor (TGCT) use the drug vimseltinib in everyday medical practice. It will observe about 100 patients who are already prescribed this medication to see how long they stay on treatment and how it affects their quality of life. This is an observational study, meaning researchers will only collect information and will not change anyone's treatment plan.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TENOSYNOVIAL GIANT CELL TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Synexus Clinical Research, US INC
RECRUITINGWilmington, North Carolina, 28401, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.